How Medicines are Approved and Funded in New Zealand
The process in New Zealand begins with the release of data supporting the introduction of a new medicine. Our regulatory team here in NZ then engages with Medsafe. Medsafe makes the call on efficacy (effectiveness) and safety of all medicines licensed in NZ. This is an essential step in bringing the most appropriate medicines to the right patients and involves large dossiers of data requiring expert regulatory analysis.
Following Medsafe’s review and approval, our small but expert team ensure we understand fully what our clinicians here in NZ want for their patients. We then engage with PHARMAC to negotiate the best deals that we can bring to NZ, fulfilling contracts of supply, and ensuring a high quality product reaches the customer and our clinicians have the essential information they require to prescribe and administer these medicines.
Once submitted, PHARMAC has an established process for deciding which medicines to fund. Of all our registered medicines, two thirds are funded by PHARMAC.
Click here to understand how medicines are made available for Kiwis.